hotspot -WSS

hotspot

author：leisure time 2025-09-14 10:09:19 - browse：8

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： FDA panel issues narrow recommendation for Covid vaccine booster doses

explore

WSS

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Biden will tout long

In medicine, common shorthands can shortchange care

How to use technology to prevent future drug shortages

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

focus

hotspot

leisure time

Jerome Adams on the need for new antivirals for Covid

Man killed during FBI raid in connection with threats against Biden, other officials

Supreme Court strikes down use of affirmative action

Biden will tout long

Hepatitis C has a cure — but many Americans still lack access to it

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

United colonoscopy coverage change 'may cost lives,' doctors say

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

Hepatitis C has a cure — but many Americans still lack access to it

NYC plans to house migrants on an island in the East River

entertainment

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Why failed clinical trials don’t always spell doom for a new drug

Police still searching for prisoner who escaped from NYC hospital